Hofseth BioCare and Hofseth International
CLP has assisted Hofseth BioCare with its continued turnaround project consisting of inter alia an acquisition of 15 percent of the shares in HFS Alliance in Tokyo, an equity issue of approximately NOK 165 million, including a buyback and conversion of convertible bonds, together with a subsequent offering. Furthermore, CLP assisted Hofseth International with the acquisition of Fjordlaks Aqua through a joint venture with Yokohama Reito.
The key attorneys handling the matters were Edvard Cock, Eivin Johnsrud, Amund Erdal and Jørgen Gran.
Read more about the turnaround project and the acquisition.